These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 9549808)

  • 1. Quality of life assessment in International Breast Cancer Study Group (IBCSG) trials: practical issues and factors associated with missing data.
    Bernhard J; Peterson HF; Coates AS; Gusset H; Isley M; Hinkle R; Gelber RD; Castiglione-Gertsch M; Hürny C
    Stat Med; 1998 Mar 15-Apr 15; 17(5-7):587-601. PubMed ID: 9549808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quality of life assessment in patients receiving adjuvant therapy for breast cancer: the IBCSG approach. The International Breast Cancer Study Group.
    Bernhard J; Hürny C; Coates AS; Peterson HF; Castiglione-Gertsch M; Gelber RD; Goldhirsch A; Senn HJ; Rudenstam CM
    Ann Oncol; 1997 Sep; 8(9):825-35. PubMed ID: 9358933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Timing of baseline quality of life assessment in an international adjuvant breast cancer trial: its effect on patient self-estimation. The International Breast Cancer Study Group.
    Hürny C; Bernhard J; Coates A; Castiglione M; Peterson HF; Gelber RD; Rudenstam CM; Goldhirsch A; Senn HJ
    Ann Oncol; 1994 Jan; 5(1):65-74. PubMed ID: 8172795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quality of life assessment in the International Breast Cancer Study Group: past, present, and future.
    Hürny C; Bernhard J; Coates A
    Recent Results Cancer Res; 1998; 152():390-5. PubMed ID: 9928574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors affecting baseline quality of life in two international adjuvant breast cancer trials. International Breast Cancer Study Group (IBCSG).
    Bernhard J; Hürny C; Coates AS; Peterson HF; Castiglione-Gertsch M; Gelber RD; Galligioni E; Marini G; Thürlimann B; Forbes JF; Goldhirsch A; Senn HJ; Rudenstam CM
    Br J Cancer; 1998 Sep; 78(5):686-93. PubMed ID: 9744512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Missing data in quality of life research in Eastern Cooperative Oncology Group (ECOG) clinical trials: problems and solutions.
    Hahn EA; Webster KA; Cella D; Fairclough DL
    Stat Med; 1998 Mar 15-Apr 15; 17(5-7):547-59. PubMed ID: 9549804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Compliance with QOL assessment in multi-centre German breast cancer trials.
    Olschewski M
    Stat Med; 1998 Mar 15-Apr 15; 17(5-7):571-5. PubMed ID: 9549806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quality of life studies of the Australian New Zealand Breast Cancer Trials Group: approaches to missing data.
    Coates A; Gebski V
    Stat Med; 1998 Mar 15-Apr 15; 17(5-7):533-40. PubMed ID: 9549802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical trial update: International Breast Cancer Study Group.
    Price KN; Goldhirsch A;
    Breast Cancer Res; 2005; 7(6):252-4. PubMed ID: 16280051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Compliance issues in quality of life assessment: experiences of two Cancer Research Campaign sponsored groups.
    Fallowfield L
    Stat Med; 1998 Mar 15-Apr 15; 17(5-7):541-6. PubMed ID: 9549803
    [No Abstract]   [Full Text] [Related]  

  • 11. Compliance with quality of life data collection in the National Surgical Adjuvant Breast and Bowel Project (NSABP) Breast Cancer Prevention Trial.
    Ganz PA; Day R; Costantino J
    Stat Med; 1998 Mar 15-Apr 15; 17(5-7):613-22. PubMed ID: 9549810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ensuring the quality of quality of life data: the Southwest Oncology Group experience.
    Moinpour CM; Lovato LC
    Stat Med; 1998 Mar 15-Apr 15; 17(5-7):641-51. PubMed ID: 9549813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quality of life measures for patients receiving adjuvant therapy for breast cancer: an international trial. The International Breast Cancer Study Group.
    Hürny C; Bernhard J; Gelber RD; Coates A; Castiglione M; Isley M; Dreher D; Peterson H; Goldhirsch A; Senn HJ
    Eur J Cancer; 1992; 28(1):118-24. PubMed ID: 1567662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quality-of-life-adjusted evaluation of adjuvant therapies for operable breast cancer. The International Breast Cancer Study Group.
    Gelber RD; Goldhirsch A; Cavalli F
    Ann Intern Med; 1991 Apr; 114(8):621-8. PubMed ID: 2003707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quality of life as an endpoint in EORTC clinical trials. European Organization for Research and Treatment for Cancer.
    Kiebert GM; Curran D; Aaronson NK
    Stat Med; 1998 Mar 15-Apr 15; 17(5-7):561-9. PubMed ID: 9549805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The multi-centre assessment of quality of life: the Interdisciplinary Group for Cancer Care Evaluation (GIVIO) experience in Italy.
    Mosconi P; Torri V; Cifani S; Ruggiata R; Meyerowitz BE; Apolone G; Liberati A
    Stat Med; 1998 Mar 15-Apr 15; 17(5-7):577-85. PubMed ID: 9549807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Practical issues in quality of life assessment in multicentre trials conducted by the Swiss Group for Clinical Cancer Research.
    Bernhard J; Gusset H; Hürny C
    Stat Med; 1998 Mar 15-Apr 15; 17(5-7):633-9. PubMed ID: 9549812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Impact of Age on Quality of Life in Breast Cancer Patients Receiving Adjuvant Chemotherapy: A Comparative Analysis From the Prospective Multicenter Randomized ADEBAR trial.
    Leinert E; Singer S; Janni W; Harbeck N; Weissenbacher T; Rack B; Augustin D; Wischnik A; Kiechle M; Ettl J; Fink V; Schwentner L; Eichler M
    Clin Breast Cancer; 2017 Apr; 17(2):100-106. PubMed ID: 27884722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of adjuvant therapy on quality of life in women with node-positive operable breast cancer. International Breast Cancer Study Group.
    Hürny C; Bernhard J; Coates AS; Castiglione-Gertsch M; Peterson HF; Gelber RD; Forbes JF; Rudenstam CM; Simoncini E; Crivellari D; Goldhirsch A; Senn HJ
    Lancet; 1996 May; 347(9011):1279-84. PubMed ID: 8622502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Timing of quality of life (QoL) assessments as a source of error in oncological trials.
    Hakamies-Blomqvist L; Luoma ML; Sjöström J; Pluzanska A; Sjödin M; Mouridsen H; Østenstad B; Mjaaland I; Ottosson S; Bergh J; Malmström PO; Blomqvist C
    J Adv Nurs; 2001 Sep; 35(5):709-16. PubMed ID: 11529973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.